Skip to main content

Table 2 Correlation between end-stage renal disease patients’ clinical features and erythropoietin (EPO) responsiveness

From: V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

 

EPO responders

EPO non-responders

P valuea

Age (yr)

59.0 ± 10.8

56.7 ± 9.3

0.746

Ferritin (mg/dL)

262.2 ± 117.3

430.7 ± 326.5

0.327

Fe (μg/dL)

71.8 ± 22.8

61.7 ± 17.9

0.507

TIBC (μg/dL)

258.0 ± 22.0

228 ± 3.6

0.080

Alb (g/dL)

4.2 ± 0.3

4.4 ± 0.1

0.355

MCV (fL)

92.8 ± 4.3

91.3 ± 2.1

0.584

PTH (pg/mL)

256.8 ± 102.1

455.3 ± 320.1

0.248

Kt/V

1.4 ± 0.3

1.6 ± 0.3

0.506

Hb (g/dL)

11.7 ± 0.9

9.9 ± 0.6

0.048b

  1. a P values were calculated by asymptotic two-sample Fisher-Pitman permutation test. TIBC total iron-binding capacity, Alb albumin, MCV mean corpuscular volumn, PTH parathyroid hormone, Kt/V (dialyzer clearance of urea)×(dialysis time)/(volume of distribution of urea); Hb, hemoglobin. b P-value < 0.05
Back to article page

Journal of Biomedical Science

ISSN: 1423-0127